Uterine Neoplasms Clinical Trial
Official title:
A Development of an In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure Using FTIR-ATR Spectroscopy
The aim of the current study is to develop a near real-time system using infrared spectroscopy, that will evaluate the histological specimen that was removed from the uterine cavity during the hysteroscopy.
| Status | Not yet recruiting |
| Enrollment | 300 |
| Est. completion date | May 2021 |
| Est. primary completion date | May 2021 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Patients undergoing hysteroscopy Exclusion Criteria: - Pregnancy |
| Country | Name | City | State |
|---|---|---|---|
| Israel | Hillel Yaffe Medical Center | Hadera |
| Lead Sponsor | Collaborator |
|---|---|
| Hillel Yaffe Medical Center |
Israel,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Comparison of infrared spectroscopy with routine histopathology | Tissue smears that have undergone infrared spectroscopy during hysteroscopy will have a different spectral absorption than healthy tissue, thus indicating malignancy. These results will be compared to the results of routine histopathology to determine accuracy of spectroscopy to indicate malignancy. | 3 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02374411 -
Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients
|
N/A | |
| Completed |
NCT00377520 -
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
|
Phase 2 | |
| Recruiting |
NCT04063072 -
ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Hysterectomy.
|
N/A | |
| Terminated |
NCT01969396 -
Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology
|
N/A | |
| Terminated |
NCT00669422 -
ChemoFx® PRO - A Post-Market Data Collection Study
|
N/A | |
| Recruiting |
NCT01564264 -
Sentinel Node Biopsy in Endometrial Cancer
|
N/A | |
| Completed |
NCT00231855 -
Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers
|
Phase 2 | |
| Completed |
NCT04679675 -
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
|
N/A | |
| Completed |
NCT04351139 -
Impact of the COVID-19 Pandemic in Gynecological Oncology
|
||
| Completed |
NCT05004623 -
Early Feasibility Study of the "Easy Light" Fluorecence Imaging System
|
N/A | |
| Completed |
NCT00112307 -
Magnetic Resonance Imaging Guided Gynecologic Brachytherapy
|
N/A | |
| Completed |
NCT02454036 -
Biobehavioral Intervention in Gynecologic Oncology Patients
|
Phase 2 | |
| Completed |
NCT00188578 -
Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03951415 -
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer
|
Phase 2 | |
| Completed |
NCT01654458 -
A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer
|
N/A | |
| Completed |
NCT00190918 -
A Trial for Patients With Gestational Trophoblastic Disease
|
Phase 2 | |
| Completed |
NCT00050440 -
Phase 2 Study of ET-743 (Trabectedin) in Patients With Persistent or Recurrent Endometrial Carcinoma
|
Phase 2 | |
| Completed |
NCT00250783 -
Pre-Clinical Models in Gynecological Tumors A Tissue Repository
|
||
| Recruiting |
NCT03624712 -
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
|
||
| Completed |
NCT00628901 -
A Prospective Study Comparing Contour SE™ Microspheres to Embosphere® Microspheres for Treating Symptomatic Uterine Fibroids With Uterine Fibroid Embolization (UFE)
|
Phase 4 |